Analyst Price Target is $1.00
▼ -53.77% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for XWELL in the last 3 months. The average price target is $1.00, with a high forecast of $1.00 and a low forecast of $1.00. The average price target represents a -53.77% upside from the last price of $2.16.
Current Consensus is
The current consensus among 1 investment analysts is to buy stock in XWELL. This Buy consensus rating has held steady for over two years.
XWELL, Inc., a health and wellness services company, provides spa services at airports. It operates through XpresSpa, XpresTest, Treat, and HyperPointe segments. The company offers spa services, including massage, and nail and skin care, as well as spa and travel products; and retail products. It also provides diagnostic COVID-19 tests at XpresCheck wellness centers in airports; and other medical diagnostic testing services. In addition, the company offers marketing support to health and health-related channels. It operates stores, as well as offers its services through an integrated digital platform. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL, Inc. in October 2022. XWELL, Inc. was founded in 2006 and is headquartered in New York, New York.